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Repetitive sequences account for more than 50% of
the human genome. Facioscapulohumeral muscular
dystrophy (FSHD) is an autosomal-dominant disease
associated with reduction in the copy number of the
D4Z4 repeat mapping to 4q35. By an unknown
mechanism, D4Z4 deletion causes an epigenetic
switch leading to de-repression of 4q35 genes.
Here we show that the Polycomb group of epigenetic
repressors targets D4Z4 in healthy subjects and
that D4Z4 deletion is associated with reduced Poly-
comb silencing in FSHD patients. We identify
DBE-T, a chromatin-associated noncoding RNA
produced selectively in FSHD patients that coordi-
nates de-repression of 4q35 genes. DBE-T recruits
the Trithorax group protein Ash1L to the FSHD locus,
driving histone H3 lysine 36 dimethylation, chromatin
remodeling, and 4q35 gene transcription. This study
provides insights into the biological function of repet-
itive sequences in regulating gene expression and
shows howmutations of such elements can influence
the progression of a human genetic disease.
INTRODUCTION
Facioscapulohumeral muscular dystrophy (FSHD) (MIM 158900)
is one of themost commonmyopathies (Cabianca and Gabellini,
2010). It is an autosomal-dominant disease characterized by
progressive wasting of facial, upper arm, and shoulder girdle
muscles. In up to 95% of cases, the genetic defect is mapped
to the subtelomeric region of chromosome 4q35. Remarkably,
FSHD patients do not carry a classical mutation within a
protein-coding gene. FSHD is rather caused by deletions
reducing the copy number of the 3.3 kb D4Z4 repeat below 11units. D4Z4 is extremely polymorphic in the general population
and belongs to a family of human noncentromerically located
tandem repeats termed macrosatellites (Chadwick, 2009).
Several FSHD features, such as variability in severity and rate
of progression, gender bias in penetrance, asymmetric muscle
wasting, and monozygotic twin discordance, strongly suggest
the involvement of epigenetic factors (Neguembor and Gabellini,
2010). Accordingly, DNA methylation (van Overveld et al., 2003),
histonemarks (Bodega et al., 2009; Zeng et al., 2009), and higher
order chromatin structure (Bodega et al., 2009; Petrov et al.,
2006; Pirozhkova et al., 2008) are altered in FSHDpatients. These
changes have been associated with the inappropriate
de-repression of several 4q35 genes, among which DUX4 is
currently the leading FSHDcandidate (Gabellini et al., 2002; Lem-
mers et al., 2010). However, themolecularmechanismunderlying
the epigenetic switch at the basis of FSHD is currently unknown.
Polycomb (PcG) and Trithorax (TrxG) group proteins act
antagonistically in the epigenetic regulation of gene expression.
Typically, TrxG counteracts PcG-mediated epigenetic gene
silencing. PcG and TrxG factors play crucial roles in many bio-
logical aspects such as cell proliferation, stem cell identity, and
X inactivation (Schuettengruber et al., 2007). In Drosophila,
PcG and TrxG bind to specific DNA regions termed Polycomb/
Trithorax response elements (PREs/TREs), constituting a regu-
lated switchable element that influences chromatin architecture
and expression of nearby genes (Ringrose and Paro, 2004;
Schuettengruber et al., 2007).
D4Z4 shares several features with PREs/TREs (Figure S1
available online). In healthy subjects, D4Z4 is organized as
repressed chromatin and displays the PcG-associated histone
mark H3K27me3 (histone H3 lysine 27 tri-methylation) (Bodega
et al., 2009; Jiang et al., 2003; van Overveld et al., 2003; Zeng
et al., 2009). Interestingly, in FSHD patients loss of repressive
marks and 4q35 genes de-repression has been reported
(Bodega et al., 2009; Dixit et al., 2007; Gabellini et al., 2002;
Rijkers et al., 2004). Each D4Z4 unit contains copies of a motif
nearly identical to a conserved sequence (CNGCCATNDNND)Cell 149, 819–831, May 11, 2012 ª2012 Elsevier Inc. 819
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found in Drosophila PREs (Gabellini et al., 2002; Mihaly et al.,
1998). This sequence overlaps with DBE (D4Z4 binding element),
a region necessary and sufficient to confer copy-number-depen-
dent repressive activity (Gabellini et al., 2002) due to its ability to
recruit YY1, EZH2, and HMGB2 (human homologs of the
Drosophila PcG proteins Pho and E(z) and the PcG recruiter
Dsp1, respectively) (Bodega et al., 2009; De´jardin et al., 2005;
Gabellini et al., 2002). The region surrounding DBE is enriched
in putative binding sites for GAGA factor (Gaf), a DNA-binding
protein implicated in PRE function in Drosophila (Busturia
et al., 2001; Mishra et al., 2001). Finally, a role for CpG-rich
regions in PcG recruitment in mammals has been suggested
(Mendenhall et al., 2010), and the region occupied by D4Z4 in
healthy subjects is one of the biggest CpG islands of the human
genome (Neguembor and Gabellini, 2010).
In Drosophila, the TrxG protein Ash1 plays a crucial role in de-
repression of PcG targets (Beisel and Paro, 2011; Papp and
Mu¨ller, 2006; Schwartz et al., 2010) and can be recruited by
ncRNAs (Sanchez-Elsner et al., 2006). Interestingly, ASH1L,
the mammalian homolog of fly Ash1, was shown to occupy
actively transcribed chromatin (Gregory et al., 2007). However,
the exact function of Ash1L and how it is recruited to its targets
are poorly understood.
Here, we investigated the possibility that transcription of DBE
regulates the epigenetic switch responsible for de-repression of
the FSHD locus.
RESULTS
D4Z4 Recruits Polycomb Complexes to Repress 4q35
Genes
By 3D fluorescence in situ hybridization (3D-FISH), the PcG hall-
mark H3K27me3 was shown to be reduced selectively on the
contracted 4q35 allele in FSHD primary muscle cells (Bodega
et al., 2009). This suggested that contraction of D4Z4 repeats
could determine a loss of Polycomb silencing in FSHD. We
used chromatin immunoprecipitation followed by real-time
PCR (ChIP-qPCR) to analyze levels of EZH2 and H3K27me3 in
primary muscle cells. In healthy subjects, EZH2 was enriched
on the entire D4Z4 unit and on regions immediately proximal to
the repeat array (Figure 1B), including an element that we called
NDE (for nondeleted element) because it is always maintained in
FSHD patients regardless of their type of deletion (Lemmers
et al., 2003). H3K27me3 was also enriched on the same regions
but showed a peak on NDE (Figure 1C). Intriguingly, in FSHDFigure 1. D4Z4 Recruits PcG Complexes to Repress 4q35 Genes
(A–C) ChIP for EZH2, H3K27me3, and IgG on primary muscle cells from healthy
analysis (A). ChIP analyzed by qPCR for p13E-11, nondeleted element (NDE),
enrichment to input normalized for repeat amount (B), or percentage of total H3
patients is shown. The error bars represent SEM. Asterisks indicate statistical
respectively p = 0.0051 (B) and p = 0.0497 (C).
(D–F) CHO cells stably transfected with human 4q35 BACs either containing (CH
were analyzed by ChIP for core components of PRC1 and H2Aub1 (E) and PRC
common to both BACs (see scheme D). Results are expressed as percentage of in
normalized to IgM (H2Aub1). The error bars represent SEM.
(G–J) Chr4/CHO cells stably expressing control shRNA or shSuz12. Knockdown w
Gapdh (I) and 4q35 genes ANT1, FRG1, FRG2, and DUX4 was analyzed by qRT
See also Figures S1 and S2.patients, D4Z4 deletion was associated with a significant reduc-
tion of EZH2 at the FSHD locus (Figure 1B) and this translated
into a significant decrease of H3K27me3 on the regions immedi-
ately proximal to the repeat array, including NDE (Figure 1C).
We found that in healthy subjects EZH2 and H3K27me3 were
enriched above background at the promoters of ANT1, FRG1,
and FRG2, even though they were at lower levels than those in
NDE (Figures S2A and S2B). In FSHD patients, a trend toward
a reduction in EZH2 and H3K27me3 enrichment at 4q35 genes
promoters was observed (Figures S2A and S2B).
The selective study of 4q-located D4Z4 repeats in human
samples is challenged by the presence of D4Z4-like sequences
on almost all human acrocentric chromosomes (Lyle et al., 1995;
Winokur et al., 1994). By sequencing the PCR products of
our Polycomb ChIP-qPCRs performed on human samples, we
did not find D4Z4-like sequences, suggesting that D4Z4-like
repeats elsewhere in the genome are not associated with PcG
binding.
Because D4Z4 is a primate-specific repeat (Clark et al., 1996),
genetic mouse models of FSHD (displaying for example
a different number of D4Z4 repeats) cannot be generated. Never-
theless, we exploited the above limitation by using human/
rodent monochromosomal hybrid cells containing, in a CHO
background, a single human chromosome 4 derived from
a healthy subject (chr4/CHO). In this setting, the only D4Z4
source is the human chromosome 4. Importantly, we confirmed
that human chr4/CHO cells display all the epigenetic features
typically found at the FSHD locus in healthy subjects including
DNA hypermethylation (van Overveld et al., 2003), histone hypo-
acetilation (Jiang et al., 2003), enrichment of cohesin, HP1g and
H3K9me3 (Zeng et al., 2009), and repression of 4q35 genes
(C. Huichalaf and D. Gabellini, unpublished data).
PcG proteins are found in several families of multiprotein
complexes. The two main complexes are termed Polycomb
Repressive Complex 1 and 2 (PRC1 and PRC2). In mammals,
there are multiple versions of PRC1 and PRC2 due to the pres-
ence of many alternative subunits (Margueron and Reinberg,
2011).We focused our analysis on core PRC1 and PRC2 compo-
nents. By ChIP-qPCR in chr4/CHO cells, we found that the PRC1
components Bmi1, Rae28, and Ring1B are enriched on the
entire D4Z4 unit and onNDE (Figure S2D). Intriguingly, the typical
PRC1 repressive histone mark H2Aub1 (histone H2A mono-
ubiquitinated on lysine 119) was enriched on the same regions
but showed a peak on NDE (Figure S2D). For PRC2, we analyzed
the core subunits Eed, Ezh2, and Suz12. Similarly to PRC1,donors and FSHD patients. A scheme of the FSHD locus primers used for the
and different regions of the D4Z4 repeat. Results are expressed as relative
(C). The mean of the signals obtained from four healthy samples or four FSHD
significance (p value) as evaluated by two-way repeated-measured ANOVA,
16-291A23) or lacking (RP11-462G22) 4q35 D4Z4 repeats (schematized in D),
2 and H3K27me3 (F). ChIP was analyzed by qPCR with primers for a region
put (PcG proteins), percentage of total H3 (H3K27me3), or percentage of H2A,
as evaluated by qRT-PCR (G) and immunoblotting (H). Expression of Hoxd11,
-PCR (J) and expressed over b-actin. The error bars represent SEM.
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PRC2 and its repressive mark, H3K27me3, were enriched over
the entire FSHD locus (Figure S2E), with H3K27me3 showing
a peak on NDE (Figure S2E).
Several proteins collaborate to recruit Polycomb to PREs
(Margueron and Reinberg, 2011). Interestingly, Figure S2F
shows that two PcG recruiters, Jarid2 (Landeira and Fisher,
2011) and c-Krox/Th-POK (the putative vertebrate homolog of
GAGA factor, Busturia et al., 2001; Matharu et al., 2010; Mishra
et al., 2001), were enriched at the FSHD locus. Furthermore, the
repressive histone variant macroH2A, overlapping locally and
functionally with PRC2 (Buschbeck et al., 2009), was enriched
at the FSHD locus (Figure S2G). Notably, ChIP-qPCR signals
at D4Z4 were comparable to those observed on the bona fide
PcG target Hoxd11 (Woo et al., 2010) (Figures S2D–S2G).
One of the features of PREs is their ability to recruit PcG
complexes when inserted in ectopic sites. To test this, we intro-
duced in CHO cells human 4q35 bacterial artificial chromo-
somes (BACs) either containing or lacking D4Z4 repeats (Fig-
ure 1D). To directly compare Polycomb recruitment, we
performedChIP-qPCRwith primersmapping on the insert-flank-
ing region common to both BACs. As shown in Figures 1E and
1F, we found robust recruitment for PRC1, PRC2, and their asso-
ciated repressive histone marks selectively in the BAC-contain-
ing D4Z4 repeats. This result indicates that D4Z4 repeats are
able to initiate de novo recruitment of Polycomb complexes.
Based on our results, we hypothesized that D4Z4 recruits
Polycomb complexes to repress 4q35 genes. We tested this
directly by performing RNAi-mediated loss of Polycomb. As
shown in Figures 1G–1J, Suz12 knockdown caused a de-repres-
sion of 4q35 genes comparable to that of the bona fide Poly-
comb target gene Hoxd11.
Altogether, our results strongly suggest that loss of Polycomb
silencing is responsible for de-repression of 4q35 genes in FSHD
patients.
Transcription of DBE Occurs Selectively
in FSHD Patients and Is Associated with
4q35 Gene De-Repression
It has been reported that transcription of ncRNAs from PREs
could play a role in relief of PcG-mediated silencing inDrosophila
(Bae et al., 2002; Lipshitz et al., 1987; Rank et al., 2002; Sanchez-
Elsner et al., 2006; Schmitt et al., 2005). Because of the similar-
ities between DBE and PREs, we analyzed transcription from
DBE (Figure 1A). We performed real-time RT-PCR (qRT-PCR)
on total RNA extracted from muscle biopsies or primary muscle
cells from healthy subjects and FSHD patients. Figure 2A shows
that DBE was transcribed above background exclusively in
FSHD samples to generate an RNA that we named DBE-T
(DBE-Transcript). As stated above, D4Z4-like sequences are
located on several human chromosomes (Lyle et al., 1995;Wino-
kur et al., 1994). To verify the chromosomal origin of DBE-T, we
extensively sequenced the qRT-PCR products from muscle
biopsies and primary muscle cells to take advantage of 4q35-
specific SNPs. Notably, 97%of the products were 4q35 specific,
indicating that DBE-T originated from the FSHD-associated
locus. To confirm this, we again took advantage of human
chr4/CHO cells. In this system, the de-repression of 4q35 genes
due to RNAi-mediated loss of Polycomb (Figure 1J) was associ-822 Cell 149, 819–831, May 11, 2012 ª2012 Elsevier Inc.ated with DBE-T production (Figure 2B). We have recently found
that DNA methylation and histone deacetylation are required
for keeping the 4q35 region repressed (C. Huichalaf and
D. Gabellini, unpublished data). As a consequence, treatment
with AZA (5-Aza-20-deoxycytidine) plus TSA (Trichostatin A)
(inhibitors of DNA methylation and histone de-acetylation,
respectively) resulted in de-repression of 4q35 genes (Figure 2C).
Intriguingly, also in this case 4q35 gene de-repression was
paralleled by production of DBE-T (Figure 2C).
Several elements suggested that AZA plus TSA effects on the
FSHD locus were fairly specific. Histone deacetylation has a role
in PRC1-mediated chromatin compaction (Eskeland et al., 2010)
and TSA treatment causes relief of Polycomb silencing (Garrick
et al., 2008). In chr4/CHO cells, AZA plus TSA treatment caused
a dramatic de-repression of the bona fide PcG target Hoxd11,
whereas the expression of the non-PcG target Gapdh was unaf-
fected, suggesting that loss of PcG silencing was not due to
unspecific effects of the treatment (Figure 2D). Finally, AZA treat-
ment did not affect the number of D4Z4 repeats nor reduce PcG
binding or H3K27me3 enrichment (Figure S3).
DBE-T Regulates 4q35 Chromatin Structure and Gene
De-Repression
As shown above, in independent systems DBE-T production
is always associated with de-repression of 4q35 genes. To
address its biological role, we generated chr4/CHO stable cells
expressing a DBE-T shRNA or a control, nonsilencing shRNA.
Remarkably, DBE-T knockdown prevented 4q35 gene de-
repression caused by AZA plus TSA, strongly suggesting a
functional role for this transcript in the positive regulation of
4q35 gene expression (Figure 3A).
shRNAs can directly cause epigenetic changes by transcrip-
tional gene silencing (TGS) (Turner and Morris, 2010), raising
the possibility that DBE-T shRNAs could cause TGS at the
FSHD locus. Importantly, treatment with AZA plus TSA prevents
TGS because it is strictly dependent on the activity of DNA
methyltransferases and histone deacetylases (Morris et al.,
2004; Turner and Morris, 2010). Given that we investigated
effects of DBE-T shRNAs in cells treated with AZA plus TSA, it
was extremely unlikely that TGS could play a role in our findings.
To further address this, we analyzed recruitment of Ago1, which
is required for TGS (Kim et al., 2006). We used ChIP-qPCR to
monitor Ago1 recruitment on NDE, DBE, and b-actin, which is
unaffected by treatment with DBE-T shRNAs, as control. As
shown in Figure S4, at all regions analyzed Ago1 displayed a
very low enrichment that was unaltered by DBE-T shRNAs (Fig-
ure S4). These results indicate that DBE-T shRNAs do not cause
TGS but only posttranscriptional degradation of the intended
target RNA.
It has been reported that a chromatin reorganization is associ-
ated with 4q35 gene de-repression (Bodega et al., 2009; Petrov
et al., 2006; Pirozhkova et al., 2008). In particular, chromatin
conformation capture (3C) detected an interaction between
D4Z4 and the promoter of the 4q35 gene FRG1 that is reduced
in FSHD patients compared to controls (Bodega et al., 2009).
We confirmed this interaction in chr4/CHO cells and found that
it is reducedwhenDBE-T is produced and FRG1 is de-repressed
(Figure 3C, left, and Figure 2C). Notably, DBE-T knockdown
Figure 2. The DBE Region Is Transcribed Selectively in FSHD Patients or FSHD-Like Conditions
(A) qRT-PCR analysis of DBE-T in muscle biopsies (left) and primary muscle cells (right) from healthy donors and FSHD patients. Results are expressed over
GAPDH.
(B) qRT-PCR analysis of DBE-T in control or Suz12 knockdown chr4/CHO cells. Results are expressed over b-actin.
(C) qRT-PCR analysis of 4q35 genes and DBE-T in chr4/CHO cells in the repressed (control) or de-repressed (AZA+TSA) states. Results are expressed over
b-actin.
(D) qRT-PCR analysis of Hoxd11 andGapdh in chr4/CHO cells in the repressed (control) or de-repressed (AZA+TSA) states. Results are expressed over b-actin.
The error bars represent SEM.
See also Figure S3.prevented the topological reorganization of the FSHD region
characteristic of the de-repressed state (Figure 3C, right).
Thus, DBE-T is involved in the regulation of 4q35 higher order
chromatin structure and is required for 4q35 gene de-repression.
DBE-T Functions in cis and Is Associated with the
Chromatin of the FSHD Locus
To dissect the role of DBE-T in 4q35 gene de-repression, we
asked whether DBE-T ectopic expression could be sufficient tode-repress 4q35 genes. To this aim, chr4/CHO cells were tran-
siently transfected with a construct producing DBE-T. In qRT-
PCR assays, DBE-T overexpression was unable to de-repress
4q35 genes in trans (Figure S5).
To further elucidate DBE-T mechanism of action, we investi-
gated its subcellular localization by using independent
approaches. First, through biochemical fractionation we found
that DBE-T was nuclear and mainly chromatin-associated and
behaved similarly to the chromatin-bound ncRNA Xist, whereasCell 149, 819–831, May 11, 2012 ª2012 Elsevier Inc. 823
Figure 3. DBE-T Is Required for De-Repression and Topological Reorganization of the 4q35 Region
(A) Control or DBE-T chr4/CHO knockdown cells were treated with AZA+TSA. DBE-T knockdown, 4q35 genes and Gapdh expression were evaluated by qRT-
PCR. Results are expressed over b-actin. The error bars represent SEM.
(B) Schematic representation of the region analyzed by 3C. The D1 3C primer, located near DBE, was used as bait and primers spanning the FRG1 genomic locus
were tested for interaction. 3C results show the relative frequency of interaction between DBE and FRG1 locus in control and AZA+TSA treated chr4/CHO cells
expressing a nonsilencing shRNA (C left) or an shRNA specific for DBE-T (shDBE-T) (C right). The error bars represent SEM.
See also Figures S4 and S5.the protein-coding mRNA Gapdh was preferentially enriched in
the cytoplasm, as expected (Figure 4A). Next, we used sequen-
tial RNA/DNA FISH to investigate the exact location of DBE-T
inside the nucleus. We first hybridized nondenatured cells with
LNA oligonucleotides targeting DBE-T. Next, cells were dena-
tured to allow for DNA detection and hybridized with DNA oligo-
nucleotides, mapping to the D4Z4 repeat in order to visualize the
4q35 locus (schematized in Figure 4B). As shown in Figure 4C,
DBE-T and D4Z4 signals colocalized in 98.8% of the cells
analyzed, indicating that DBE-T is specifically associated with
the FSHD locus. Importantly, to derive this conclusion we carried
out several controls. First, the DBE-T signal was absent in CHO
cells lacking D4Z4 and strongly reduced by RNase A+T1 treat-
ment in chr4/CHO cells (Figure S6A), proving that it corre-
sponded to a specific RNA. Second, using actinomycin D
(ActD), we showed that DBE-T is a mature RNA. In fact, actively
transcribed genes generate nascent transcripts, appearing as
nuclear dots in RNA FISH, which are exquisitely sensitive to
ActD. Accordingly, b-actin nascent transcripts quickly disap-
peared upon ActD treatment. On the contrary, the RNA FISH
signals corresponding to DBE-T were unaffected by ActD treat-824 Cell 149, 819–831, May 11, 2012 ª2012 Elsevier Inc.ment, strongly indicating that they corresponded to mature
RNAs (Figure S6B). Altogether, these results indicate that
DBE-T is a mature transcript associated with the chromatin of
the FSHD locus.
DBE-T Is a Long ncRNA Starting from the Region
Immediately Proximal to the D4Z4 Repeat Array
NcRNAs greater than 200 nt in length have been shown to be
involved in PcG/TrxG function (Margueron and Reinberg,
2011). Interestingly, using either NDE- or DBE-specific probes
in northern blot with polyA+ RNA, we detected transcripts as
large as 9.8 kb that were upregulated in the de-repressed state
(Figure S7B). On the contrary, a DUX4-specific probe detected
an 3 kb band (in line with the expected size of DUX4 mRNA)
not present in the NDE and DBE northern blots (Figure S7B).
Taking advantage of the experimental approach previously
used for rapid amplification of cDNA ends (RACE) of DUX4 (Ko-
waljow et al., 2007), we mapped the start of DBE-T upstream of
NDE (position 4099 of accession number AF117653, Figure S7A).
This result was supported by several independent findings. First,
we successfully amplified a single transcript spanning the 2.8 kb
Figure 4. DBE-T Is Nuclear, Chromatin-Associated, and Localized to the FSHD Locus
(A) Total RNA fromAZA+TSA treated chr4/CHO cells was separated into cytoplasmic, nuclear-soluble, and chromatin-bound fractions. The relative abundance of
DBE-T in the different fractions was measured by qRT-PCR. As control, Gapdh and Xist were analyzed. The error bars represent SEM.
(B) Schematic representation of the location of the DBE-T and D4Z4 probes.
(C) Following AZA+TSA treatment, chr4/CHO cells were analyzed by RNA/DNA FISH. A single Z stack acquired with an Olympus IX70 DeltaVision RT Decon-
volution Systemmicroscope is shown. Signals colocalizationwas detected in 98.8%of the double positive cells (n = 80) deriving from 3 independent experiments.
DBE-T is visualized in green, and the D4Z4 DNA is in red. DAPI is in blue.
See also Figures S6 and S7.from NDE to DBE (Figure S7C). Second, RT-PCR with overlap-
ping primers spanning the 3.4 kb from the DBE-T start
to the end of the DBE of the first D4Z4 repeat supported
a single AZA+TSA inducible long RNA (Figure S7D). Third, like
DBE-T, the NDE transcript is transcribed selectively when 4q35
genes are de-repressed (Figure S7E), generates a chromatin-
associated RNA (Figure S7F), is overexpressed in FSHD
muscle cells compared to controls (Figure S7G), and is 4q
specific. Accordingly, NDE stable knockdown in chr4/CHO cells
impaired de-repression of 4q35 genes (Figure S7H). Finally, NDE
and DBE-T expression was reduced by reciprocal knockdown
(Figure S7I).
Based on the above results, we propose that DBE-T is a long
RNA containing both NDE and DBE. DBE-T is clearly distinct
from the protein-coding DUX4 transcript encoded by D4Z4
considering: (1) the northern blot results; (2) that the primers
used to analyze DBE-T (Figure S7A) are unable to detect
DUX4; and (3) that DBE-T is proximal to D4Z4, whereas only
the last, most distal D4Z4 repeat can produce a stable transcript
encoding for DUX4 (Dixit et al., 2007; Lemmers et al., 2010).
We believe DBE-T to be nonprotein coding. In fact, even
though it contains open reading frames (ORFs) bigger than 100
amino acids, DBE-T is chromatin-associated, and it is generally
accepted that protein synthesis occurs only in the cytoplasm
(Dahlberg and Lund, 2004). Additionally, DBE-T does not func-
tion in trans, arguing against a protein-coding function.Collectively, our results strongly suggest that a long, chro-
matin-associated nonprotein-coding RNA (lncRNA) encompass-
ing NDE and DBE regulates gene expression at 4q35.
DBE-T Directly Recruits the TrxG Protein Ash1L
to De-Repress 4q35 Genes
Because ncRNAs were shown to recruit TrxG proteins to target
genes (Bertani et al., 2011; Sanchez-Elsner et al., 2006; Wang
et al., 2011), we investigated TrxG recruitment to the FSHD
locus. The TrxG proteins Chd7 and Mll1 were enriched at similar
levels in the repressed and de-repressed states on NDE and
DBE regions (Figure 5A). Importantly, our data on Mll1 occu-
pancy parallel what was previously described for its fly homolog
Trx, which can co-occupy repressed targets together with PcG
proteins (Papp and Mu¨ller, 2006; Schuettengruber et al., 2009;
Schwartz et al., 2010). On the contrary, the TrxG protein Ash1L
was preferentially enriched on NDE specifically in the de-
repressed state (Figure 5A). Interestingly, the recruitment of
Ash1 is the main determinant that distinguishes the repressed
from the de-repressed state in Drosophila as well (Papp and
Mu¨ller, 2006; Schwartz et al., 2010). Importantly, ChIP-qPCR
assays showed that ASH1L is recruited to the FSHD locus
preferentially in muscle cells from FSHD patients compared to
those from healthy subjects (Figure 5B). Hence, we hypothesized
that Ash1L might be involved in de-repression of 4q35 genes. To
test this, we generated stable chr4/CHO cells expressing aCell 149, 819–831, May 11, 2012 ª2012 Elsevier Inc. 825
Figure 5. The TrxG Protein Ash1L Is Recruited to the FSHD Locus and De-Represses 4q35 Genes
(A) ChIP for Ash1L, Chd7, Mll1, and IgG on chr4/CHO cells in the repressed (control) or de-repressed (AZA+TSA) states. ChIP was analyzed by qPCRwith primers
for NDE and DBE and expressed as percentage of input. The error bars represent SEM.
(B) ChIP for ASH1L in control and FSHD primarymuscle cells. ChIPwas analyzed by qPCRwith primers for NDE and expressed as percentage of input normalized
to IgG. The error bars represent SEM.
(C–F) Chr4/CHO cells stably expressing control shRNA or shAsh1L. Knockdown after AZA+TSA treatment evaluated by qRT-PCR (C), immunoblotting (D), and
ChIP on NDE (E). Expression of 4q35 genes and Gapdh, as control, was analyzed by qRT-PCR (F). Results are expressed over b-actin. The error bars represent
SEM.nonsilencing (control shRNA) or an shRNA specific for Ash1L
(shAsh1L). qRT-PCR, immunoblotting and ChIP-qPCR assays
indicated that we only partially reduced Ash1L expression and
recruitment to the FSHD locus (Figures 5C–5E). Nevertheless,
this was sufficient to impair 4q35 gene de-repression (Figure 5F).
Based on our results, we speculated that DBE-T could play
a role in the recruitment of Ash1L to the FSHD locus. To assess
this, we performed RNA immunoprecipitation following ultravi-
olet crosslinking (UV-RIP) with anti-Ash1L antibodies or IgG, as
control. DBE-T was significantly enriched in the Ash1L UV-RIP,
whereas nonrelated nuclear RNAs such as the precursor of
miR19A or the abundant U1 snRNA were not (Figure 6A).
Because UV irradiation only identifies direct protein-nucleic-
acid interactions (Greenberg, 1979), a direct Ash1L-DBE-T
interaction in vivo was suggested. To confirm this, we performed826 Cell 149, 819–831, May 11, 2012 ª2012 Elsevier Inc.in vitro pull-down experiments by using purified, recombinant
GST-Ash1L and in vitro transcribed DBE-T. GST-Ash1L was
able to directly interact with DBE-T, whereas no enrichment
was obtained by using GST alone (Figure 6B). To investigate
whether DBE-T is required for Ash1L recruitment to the FSHD
locus, we performed Ash1L ChIP-qPCR in cells knockdown for
DBE-T. DBE-T knockdown impaired the recruitment of Ash1L
to the FSHD locus (Figure 6C). Collectively, our results strongly
indicate that DBE-T functions in cis by directly recruiting Ash1L
to the FSHD locus.
Ash1L is a histone methyltransferase, but there are conflicting
reports regarding its enzymatic activity. In particular, the two
activating histone marks, H3K4me3 (histone H3 lysine 4 tri-
methylation) and H3K36me2 (histone H3 lysine 36 di-methyla-
tion), have been ascribed to Ash1L (An et al., 2011; Gregory
Figure 6. DBE-T Directly Binds the TrxG Protein Ash1L and Recruits It to the FSHD Locus
(A) RNA immunoprecipitation (IP) following UV crosslinking for Ash1L or IgG on AZA+TSA treated chr4/CHO cells. DBE-T or, as control, pre-miR19A and U1
snRNA enrichments were measured by qRT-PCR. The error bars represent SEM.
(B) In vitro RNA-GST pull-down assay showing the interaction between recombinant GST-fused Ash1L SET domain or GST and in vitro transcribedDBE-T. On the
right, Coomassie staining of purified recombinant proteins. After RNA recovery, samples were analyzed by qRT-PCR. The error bars represent SEM.
(C) Following AZA+TSA treatment, chr4/CHO cells stably expressing a nonsilencing control shRNA or shDBE-T were analyzed by ChIP for Ash1L or IgG.
Enrichment for NDE was analyzed by qPCR and displayed as enrichment relative to input. The error bars represent SEM.
(D) Upon AZA+TSA treatment, control shRNA, and shAsh1L cells were collected to analyze DBE-T expression by qRT-PCR. Results are expressed over b-actin.
The error bars represent SEM.
See also Figure S8.et al., 2007; Tanaka et al., 2007; Yuan et al., 2011). By ChIP-
qPCR, we found that both histone marks are increased in the
de-repressed state at the FSHD locus (Figure S8A). Interestingly,
Ash1L knockdown caused a decrease in H3K36me2, whereas
H3K4me3 was unaffected (Figure S8B). Moreover, H3K36me2
was also decreased by DBE-T knockdown (Figure S8C).
H3K36me2 is also the product of the ordinary process of tran-
scription elongation and does not require Ash1L (Krogan et al.,
2003). Although Ash1L and H3K36me2 were detectable above
background levels at 4q35 gene promoters, de-repression of
4q35 genes was not associated with an increase in Ash1L or
H3K36me2 at their genomic regions (Figures S8D and S8E).
Thus, the increase in H3K36me2 observed at the FSHD locus
in the de-repressed state was directly due to Ash1L recruitment.
Intriguingly, we found that Ash1L positively regulated DBE-T,
because DBE-T expression was reduced upon Ash1L knock-
down (Figure 6D). Hence, DBE-T and ASH1L could potentially
constitute a positive feedback loop that keeps the 4q35 region
de-repressed upon D4Z4 deletion.
Altogether, our results indicate that DBE-T directly recruits
ASH1L to the FSHD locus to co-ordinate 4q35 gene de-
repression.
DISCUSSION
Among the different types of muscle diseases, FSHD is undoubt-
edly one of the less characterized. Indeed, the molecular events
leading to FSHD remain undeciphered (Cabianca and Gabellini,
2010). Based on our results, we propose a model to explain theepigenetic basis of FSHD etiology. In healthy subjects, the pres-
ence of many D4Z4 units would result in extensive PcG binding,
DNA methylation, histone de-acetylation, and chromatin
compaction leading to a repressive chromatin organization (Fig-
ure 7). We propose that PcG complexes are recruited first on
D4Z4 repeats, and then silencing spreads on the region immedi-
ately proximal to the repeat array. In FSHD patients, deletion of
D4Z4 repeats results in a critical reduction of PcG silencing,
permissive for DBE-T transcription (Figure 7). Once produced
at sufficient levels, DBE-T recruits ASH1L, leading to 4q35
gene de-repression (Figure 7). Importantly, we found that
Ash1L promotes the expression of DBE-T, implying a positive
feedback loop that would sustain 4q35 gene de-repression.
On chromosomal region 10q26 is located a repeat array
almost identical and equally polymorphic to the 4q35 D4Z4 array
(Bakker et al., 1995; Cacurri et al., 1998; Deidda et al., 1996).
Nevertheless, contraction of D4Z4 repeats on 10q26 is not path-
ogenic, and FSHD is uniquely linked to 4q35 (Cacurri et al., 1998;
Lemmers et al., 1998). It has been shown that H3K9me3 is cor-
egulated on 4q35 and 10q26 D4Z4 repeats (Zeng et al., 2009),
implying that nonpathogenic 10q26 contraction should cause
loss of H3K9me3 also on 4q35. This suggests that H3K9me3
loss is not directly involved in FSHD. On the contrary, PcG
silencing and DNA methylation are reduced selectively at the
deleted 4q35 allele in FSHD (Bodega et al., 2009; van Overveld
et al., 2003) and better explain the strictly 4q35-linked nature
of the disease.
The FSHD locus is epigenetically regulated during normal
development. In particular, DUX4 is expressed in pluripotentCell 149, 819–831, May 11, 2012 ª2012 Elsevier Inc. 827
Figure 7. Model for DBE-T-Mediated 4q35 Gene De-Repression in FSHD
Normal individuals carry multiple D4Z4 copies that are extensively bound by PcG proteins, promoting the maintenance of repressed chromatin at 4q35. In FSHD
patients, D4Z4 deletion leads to insufficient binding of PcG, causing the production ofDBE-T.DBE-T recruits the TrxG protein ASH1L and promotes a topological
reorganization of the FSHD locus leading to de-repression of 4q35 genes.stem cells and in normal development, and then epigenetically
silenced in somatic tissues (Snider et al., 2010). Interestingly,
DUX4 has been retained during primate evolution, suggesting
that DUX4 might have a normal role in early embryonic muscle
development (Snider et al., 2010; Wu et al., 2010). Accordingly,
we hypothesize that the PcG/TrxG epigenetic regulation of the
FSHD locus could be important in normal muscle biology.
Recent results indicate that RNAi of a single 4q35 gene in an
FSHD animal model has a therapeutic value (Bortolanza et al.,
2011; Wallace et al., 2011). Nevertheless, the complexity of
FSHD could be better explained by envisaging it as a contiguous
gene syndrome, where the epigenetic alteration of DUX4, FRG1
and other genes collaborate to determine the final phenotype.
Hence, instead of targeting the inappropriate expression of indi-
vidual 4q35 genes, it could be more effective to target a general
4q35 genes’ regulator. Based on our results, it is tempting to
speculate that DBE-T is a valid therapeutic target to achieve
a general normalization of 4q35 gene expression in FSHD.
In Drosophila, PREs were shown to generate ncRNAs that
regulate the epigenetic status of the locus (Bae et al., 2002;
Lipshitz et al., 1987; Petruk et al., 2006; Rank et al., 2002;
Sanchez-Elsner et al., 2006; Schmitt et al., 2005). Recently, the
first example of an activatory lncRNA involved in de-repression
of a mammalian PcG target has been provided (Wang et al.,
2011). Our results indicate that DBE-T acts directly as a chro-
matin-associated lncRNA to activate the epigenetic cascade
culminating with 4q35 gene de-repression in FSHD. To the
best of our knowledge, DBE-T is the first activatory lncRNA
involved in a human genetic disease.
ASH1L occupiesmany active genes (Gregory et al., 2007), and
TrxG family proteins are involved in many cell fate decisions in828 Cell 149, 819–831, May 11, 2012 ª2012 Elsevier Inc.development and disease (Mills, 2010; Smith et al., 2011). Our
findings suggest a general function for chromatin-associated
lncRNAs in recruiting ASH1L or other chromatin-remodeling
complexes to coordinate chromosome structure and gene
expression.
A significant portion of the human genome is composed of
macrosatellite repeats (Warburton et al., 2008). Although once
thought of primarily as ‘‘junk,’’ recent studies indicate that
repeated elements play central roles in regulating gene expres-
sion at multiple levels (Faulkner et al., 2009; Kaneko et al.,
2011; Norris et al., 1995; Shen et al., 2011). Similarly to D4Z4,
other repeats displaymeiotic instability associatedwith diseases
(Bruce et al., 2009; Tremblay et al., 2010), reside within common
fragile sites that could contribute to chromosome rearrange-
ments in tumors (Tremblay et al., 2010), and are expressed
at high levels in testis and aberrantly expressed in cancer
(Gjerstorff and Ditzel, 2008; Ting et al., 2011; Tremblay et al.,
2010). Interestingly, in mammals the greatest proportion of
PcG-mediated chromatin modifications is located in genomic
repeats, and it has been suggested that they could provide
a binding platform for PcG proteins (Leeb et al., 2010). Hence,
elucidating the role of these elements in setting up functional
chromatin states in complex genomes will be of paramount
importance in upcoming years.EXPERIMENTAL PROCEDURES
Mammalian Cell Culture
CHO, HEK293T, human primary muscle cells, and human chromosome
4/CHO hybrid (GM10115) culture, stable knockdown, and treatments with
chemicals are described in the Extended Experimental Procedures.
RNA Extraction, RT-PCR, qRT-PCR, Northern Blotting, and RACE
RNA fractionation, RNA extraction, reverse transcription, real-time PCR,
northern blotting, and RACE are described in the Extended Experimental
Procedures (DBE-T accession number is JQ639078).
RNA/DNA FISH
RNA/DNA FISH was performed essentially as described in Custodio et al.
(2006). Probe sequences and experimental details are described in the
Extended Experimental Procedures.
Chromatin Immunoprecipitation
Assays were performed with normal IgG or the indicated antibodies. Precipi-
tated DNA was measured by qPCR. Primer sets and methods are described
in the Extended Experimental Procedures.
RNA ImmunoPrecipitation
This assaywascarried outmainly asdescribedpreviously (JeonandLee, 2011).
The detailed method is described in the Extended Experimental Procedures.
In Vitro RNA Pull-down Assay
Recombinant GST-fusion proteins were prepared as described previously
(Tanaka et al., 2008). In vitro RNA pull-down assay was essentially carried
out as previously described (Jeon and Lee, 2011). For a detailed protocol refer
to the Extended Experimental Procedures.
Chromosome Conformation Capture
Chromosome Conformation Capture (3C) was performed essentially as
described in Bodega et al. (2009). Primer sequences and methods are
described in the Extended Experimental Procedures.
Statistical Analyses
For EZH2 and H3K27me3 ChIP-qPCR in human samples, two-way repeated-
measured ANOVA was used.
For RNA FISH, a two-tailed, paired, t test was used.
ACCESSION NUMBERS
The GenBank accession number for DBE-T reported in this paper is
JQ639078.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
eight figures, and five tables and can be found with this article online at
doi:10.1016/j.cell.2012.03.035.
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